2022 APR 23 Dr Richard Urso Pt02 Big Pharma Makes Billions Rebranding Existing Drugs as New Products
“Basically, they took almost the exact same drug as Kaletra, dressed it up, they put a box around it, and they're selling it for what? 5 billion?”
In PART TWO of our interview with Dr. Richard Urso, co-founder of the International Alliance of Physicians and Medical Scientists, we discuss how big pharmaceutical companies can make billions by essentially repackaging existing products.
We also discuss Dr. Urso’s work with other prominent doctors to create both a national telehealth system as well as an entirely new infrastructure of doctor-led medicine, where power is decentralized and less easily corrupted.
“Once doctors became employees during this pandemic, it made them very reluctant to speak out,” Dr. Urso says.
Dr. Urso is a drug design and treatment specialist, an ophthalmologist, and former chief of orbital oncology at MD Anderson Cancer Center.
ORIGINAL SOURCE DETAILS: https://rumble.com/v123p3c-par....t-2-dr-richard-ursob
HASHTAGS: #4cminewswire, #Doctor, #RichardUrso, #Kaletra, #AndersonCancerCenter, #ACC, IAPMS, #Pharmaceutical, #BigPharma, #Rebranding, #4CMiTV, #4CM2022APR23,
TAGS: 4cminewswire, Doctor Richard Urso, Kaletra, MD Anderson Cancer Center, International Alliance of Physicians and Medical Scientists, Pharmaceutical, Big Pharma, Rebranding, 4CMiTV, #4CM2022APR23,